Researchers in London describe a new mechanism that slows down and may even prevent the natural aging of immune cells.  The findings—discovered in vitro and validated in mice—were “unexpected,” according to the University College London (UCL) team, who believe harnessing the mechanism could extend the life of the immune system, allowing people to live healthier and longer. The results could also have clinical utility for diseases such as cancer and dementia.

“Immune cells are on constant high-alert, always ready to fight pathogens,” says lead author, Dr Alessio Lanna, Honorary Professor at UCL Division of Medicine. “To be effective they also must persist for decades in the body—but the strategies employed to execute this life-long protection are largely unknown.”

The study sought to find out what mechanisms exist to confer longevity to immune system cells, known as T cells, at the initiation of the immune response against an antigen, a foreign substance recognized by the immune-surveillance mechanisms of defense of the body, Lanna says.

The work focused on telomeres, which are specific and repeating DNA sequences that form protective caps on chromosomes. These sequences have two purposes—first, to protect the coding regions of the chromosomes and prevent them from being damaged, and second, to act as an “aging clock” that controls the number of divisions a cell can make.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

Like most cells, the telomeres in T cells become shorter and shorter with each subsequent cell division, a phenomenon known as telomere attrition.  Once telomeres reach a critically short length, the cell ceases to divide and enters senescence, the process of being disposed by the immune system, or persist in an altered, dysfunctional state. With the immune system no longer functioning effectively, this leads to the onset of chronic infections, cancerous disease and death. For this reason, telomere attrition has been described as one of the “hallmarks of aging.”

In the in vitro portion of the study, the UCL team initiated an immune response of T-lymphocytes against a microbe. Unexpectedly, they observed a telomere transfer reaction between two types of white blood cells, in extracellular vesicles that facilitate intercellular communication.  An antigen presenting cell (APC), consisting either of B cells, dendritic cells or macrophages, functioned as a telomere donor, to the T lymphocyte, the telomere recipient cell. Upon transfer of the telomeres, the recipient T cell became long-lived and possessed memory and stem cell attributes, enabling the T cell to protect a host against a lethal infection in the long term.

The telomere transfer reaction extended certain telomeres about 30 times more than extension exerted by telomerase, the single DNA-synthesizing enzyme that is devoted to telomere maintenance in stem cells, cells of the immune systems, fetal tissue, reproductive cells and sperm. However, it does not provide this function in other cells, leading to telomere attrition.  Even in immune cells where the enzyme is naturally active, continuous immune reactions cause progressive telomerase inactivation leading to telomere shortening, when cells stop dividing, and replicative senescence occurs.

 “The telomere transfer reaction between immune cells adds to the Nobel-prize winning discovery of telomerase and shows that cells are capable of exchanging telomeres as a way to regulate chromosome length before telomerase action begins,” Lanna says. “It is possible that aging may be slowed down or cured simply by transferring telomeres.”

The UCL team then established that telomere extracellular vesicles can be purified from the blood, and, when added to T cells, conduct anti-aging activities in immune systems from both humans and mice. They demonstrated in both types of cells that the purified extracellular vesicle preparations may be administered alone or in combination with a vaccine and this extended durative immune protections that, in principle, may avoid need for revaccination.

Alternatively, the telomere donor transfer reaction can be boosted directly in cells. While much more research is needed, the scientists say this illustrates the possibilities of new forms of preventive therapies of immune senescence and age.

 “Telomere biology has been studied for more than 40 years. For decades, a single enzyme, telomerase, has been credited as the sole mechanism responsible for telomere elongation and maintenance in cells,” Lanna says. “Our results illuminate how a different mechanism that does not require telomerase to extend telomeres and act when telomerase is still inactive in the cell.”

The findings  were published recently in Nature Cell Biology.